Athira Pharma Inc
NASDAQ:ATHA
Cash Flow Statement
Cash Flow Statement
Athira Pharma Inc
| Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||||||||||||||
| Net Income |
(15)
|
(20)
|
(29)
|
(39)
|
(46)
|
(55)
|
(67)
|
(77)
|
(82)
|
(96)
|
(102)
|
(108)
|
(121)
|
(118)
|
(116)
|
(113)
|
(109)
|
(97)
|
(80)
|
(60)
|
(38)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Stock-Based Compensation |
0
|
1
|
2
|
3
|
4
|
5
|
6
|
8
|
10
|
11
|
11
|
11
|
11
|
11
|
11
|
11
|
11
|
11
|
10
|
8
|
7
|
|
| Other Non-Cash Items |
2
|
2
|
3
|
4
|
4
|
5
|
7
|
9
|
10
|
10
|
10
|
10
|
9
|
9
|
9
|
10
|
11
|
11
|
10
|
8
|
7
|
|
| Change in Working Capital |
(3)
|
(6)
|
(6)
|
(0)
|
6
|
6
|
7
|
4
|
(4)
|
12
|
9
|
9
|
20
|
7
|
5
|
4
|
0
|
(12)
|
(17)
|
(20)
|
(22)
|
|
| Cash from Operating Activities |
(15)
N/A
|
(24)
-57%
|
(31)
-30%
|
(35)
-10%
|
(36)
-3%
|
(43)
-21%
|
(52)
-21%
|
(64)
-22%
|
(75)
-18%
|
(72)
+3%
|
(82)
-13%
|
(88)
-7%
|
(90)
-3%
|
(101)
-12%
|
(100)
+0%
|
(98)
+2%
|
(97)
+1%
|
(97)
+0%
|
(86)
+11%
|
(71)
+18%
|
(52)
+26%
|
|
| Investing Cash Flow | ||||||||||||||||||||||
| Capital Expenditures |
(0)
|
(2)
|
(3)
|
(3)
|
(3)
|
(2)
|
(2)
|
(2)
|
(2)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
|
| Other Items |
(93)
|
(208)
|
(230)
|
(219)
|
(138)
|
(3)
|
44
|
29
|
57
|
59
|
70
|
107
|
114
|
95
|
73
|
67
|
64
|
55
|
34
|
8
|
(4)
|
|
| Cash from Investing Activities |
(93)
N/A
|
(210)
-125%
|
(233)
-11%
|
(221)
+5%
|
(141)
+36%
|
(4)
+97%
|
42
N/A
|
27
-37%
|
54
+105%
|
58
+6%
|
69
+20%
|
106
+53%
|
113
+7%
|
95
-16%
|
73
-24%
|
67
-8%
|
64
-4%
|
55
-14%
|
34
-37%
|
8
-76%
|
(4)
N/A
|
|
| Financing Cash Flow | ||||||||||||||||||||||
| Net Issuance of Common Stock |
270
|
291
|
388
|
302
|
118
|
97
|
0
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Net Issuance of Debt |
2
|
2
|
0
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash from Financing Activities |
272
N/A
|
293
+8%
|
390
+33%
|
303
-22%
|
118
-61%
|
97
-18%
|
0
-100%
|
1
+622%
|
1
-20%
|
1
+25%
|
1
-17%
|
0
-11%
|
0
N/A
|
0
+3%
|
0
-20%
|
0
-23%
|
0
+4%
|
0
-38%
|
0
N/A
|
0
N/A
|
0
-17%
|
|
| Change in Cash | ||||||||||||||||||||||
| Net Change in Cash |
163
N/A
|
59
-64%
|
126
+115%
|
47
-63%
|
(58)
N/A
|
50
N/A
|
(10)
N/A
|
(36)
-272%
|
(20)
+45%
|
(14)
+29%
|
(12)
+14%
|
19
N/A
|
24
+25%
|
(5)
N/A
|
(27)
-429%
|
(31)
-15%
|
(33)
-5%
|
(42)
-27%
|
(51)
-22%
|
(62)
-21%
|
(56)
+10%
|
|
| Free Cash Flow | ||||||||||||||||||||||
| Free Cash Flow |
(15)
N/A
|
(26)
-71%
|
(34)
-29%
|
(37)
-10%
|
(38)
-3%
|
(45)
-16%
|
(54)
-22%
|
(66)
-21%
|
(77)
-17%
|
(74)
+5%
|
(83)
-12%
|
(88)
-7%
|
(90)
-2%
|
(101)
-12%
|
(100)
+1%
|
(98)
+2%
|
(97)
+1%
|
(97)
+0%
|
(86)
+11%
|
(71)
+18%
|
(52)
+26%
|
|